UK markets close in 3 hours 44 minutes

GlaxoSmithKline plc (GLAXF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
19.89-0.24 (-1.19%)
At close: 03:34PM EST
Currency in USD

Valuation measures

Market cap (intra-day) 5101.18B
Enterprise value 3130.59B
Trailing P/E 17.74
Forward P/E 113.04
PEG ratio (5-yr expected) 13.38
Price/sales (ttm)2.29
Price/book (mrq)4.93
Enterprise value/revenue 33.92
Enterprise value/EBITDA 711.82

Trading information

Stock price history

Beta (5Y monthly) 0.40
52-week change 35.35%
S&P500 52-week change 327.11%
52-week high 321.54
52-week low 316.50
50-day moving average 319.83
200-day moving average 319.19

Share statistics

Avg vol (3-month) 358.76k
Avg vol (10-day) 31.69k
Shares outstanding 55.03B
Implied shares outstanding 6N/A
Float 84.9B
% held by insiders 11.22%
% held by institutions 152.26%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 41.09
Forward annual dividend yield 45.43%
Trailing annual dividend rate 30.80
Trailing annual dividend yield 33.97%
5-year average dividend yield 45.31
Payout ratio 493.96%
Dividend date 313 Apr 2016
Ex-dividend date 417 Nov 2021
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in GBP.

Fiscal year

Fiscal year ends 30 Dec 2020
Most-recent quarter (mrq)29 Sept 2021

Profitability

Profit margin 12.94%
Operating margin (ttm)24.78%

Management effectiveness

Return on assets (ttm)6.47%
Return on equity (ttm)23.62%

Income statement

Revenue (ttm)33.33B
Revenue per share (ttm)6.67
Quarterly revenue growth (yoy)5.00%
Gross profit (ttm)23.21B
EBITDA 10.23B
Net income avi to common (ttm)4.31B
Diluted EPS (ttm)1.14
Quarterly earnings growth (yoy)-6.10%

Balance sheet

Total cash (mrq)3.51B
Total cash per share (mrq)0.7
Total debt (mrq)25.6B
Total debt/equity (mrq)117.74
Current ratio (mrq)0.81
Book value per share (mrq)3.08

Cash flow statement

Operating cash flow (ttm)8.04B
Levered free cash flow (ttm)8.77B